Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Methods in Molecular Biology (Clifton, N.J.)|April 25, 2022
Generation, Characterization, and Count of Fluorescent Extracellular VesiclesFlavia Ferrantelli, Valentina Tirelli, Valeria Barreca, et al.
International Journal of Molecular Sciences|September 4, 2020
Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 TargetingMaria Luisa Fiani, Valeria Barreca, Massimo Sargiacomo, et al.
Pharmaceutics|June 13, 2020
Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative DiseasesFlavia Ferrantelli, Chiara Chiozzini, Patrizia Leone, et al.
Cytokine & Growth Factor Reviews|January 14, 2020
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenanceEleonora Olivetta, Chiara Chiozzini, Claudia Arenaccio, et al.
Vaccines|April 3, 2021
Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and LungsFlavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, et al.
Vaccines|May 28, 2020
N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular VesiclesChiara Chiozzini, Francesco Manfredi, Claudia Arenaccio, et al.
Vaccines|April 30, 2021
The C-Terminal Domain of Nefmut Is Dispensable for the CD8+ T Cell Immunogenicity of In Vivo Engineered Extracellular VesiclesChiara Chiozzini, Francesco Manfredi, Flavia Ferrantelli, et al.
Cancers|June 2, 2021
Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular VesiclesFlavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, et al.
Molecular Biotechnology|September 1, 2018
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and TumorsFlavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, et al.
Vaccines|July 27, 2022
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral ProteinFrancesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, et al.
Pageof 14